3 Top Performing Nifty Pharma Stocks of 2026: Granules India, Gland Pharma and Laurus Labs Lead the Index This Year
- July 20, 2026
- Posted by: Kunal Singla
- Category: News
Top performing Nifty Pharma stocks of 2026: Granules India up 47.7% YTD at Rs 883.90. Gland Pharma up 43.0%. Laurus Labs up 41.2%. Data as of 20 July 2026.
The top performing Nifty Pharma stocks of 2026 that deserve attention right now are Granules India, Gland Pharma and Laurus Labs, which have delivered gains of up to 47.7 percent since the start of the year. Pharma quietly outperformed in 2026 as CDMO demand, injectables recovery and margin expansion powered the Nifty Pharma leaders. While the wider Nifty Pharma pack produced mixed results, these names combined earnings delivery with powerful sector tailwinds.
This article breaks down the top performing Nifty Pharma stocks of 2026 with prices as of 20 July 2026, exact year to date returns calculated from 31 December 2025 closing prices, the reasons behind the rallies and the risks investors must weigh before buying.
Click Here – Get Free Investment Predictions
3 Top performing Nifty Pharma stocks of 2026 at a Glance
The table below summarises the top performing Nifty Pharma stocks of 2026 with their current market price, exact 2026 return and 52 week range as of 20 July 2026.
| Company | NSE Symbol | CMP (Rs) | 2026 Return | 52W High (Rs) | 52W Low (Rs) |
|---|---|---|---|---|---|
| Granules India | GRANULES | 883.90 | 47.7% | 910.00 | 432.60 |
| Gland Pharma | GLAND | 2,462.00 | 43.0% | 2,573.50 | 1,573.60 |
| Laurus Labs | LAURUSLABS | 1,564.90 | 41.2% | 1,579.10 | 810.05 |
A quick note on method. All 2026 returns in this article are calculated from the official closing prices of 31 December 2025 to the market price on 20 July 2026, and index membership is taken as per the latest available NSE composition. A multibagger is a stock that has delivered more than 100 percent returns over the period, while outperformers are names that have beaten the index by a wide margin without doubling yet.
1. Granules India: Leader Among Top performing Nifty Pharma stocks
Granules India has gained 47.7 percent in 2026 so far, rising from a closing price of Rs 598.50 at the end of December 2025 to Rs 883.90 as of 20 July 2026. The stock has a 52 week range of Rs 432.60 to Rs 910.00, which means it trades about 104 percent above its 52 week low and roughly 3 percent below its 52 week high.
On the fundamental side, improving margins and traction in formulations supported the rally. Investors tracking this name should follow quarterly results closely to judge whether the momentum can sustain.
2. Gland Pharma: A Consistent Outperformer of 2026
Gland Pharma has gained 43.0 percent in 2026 so far, rising from a closing price of Rs 1,722.00 at the end of December 2025 to Rs 2,462.00 as of 20 July 2026. The stock has a 52 week range of Rs 1,573.60 to Rs 2,573.50, which means it trades about 56 percent above its 52 week low and roughly 4 percent below its 52 week high.
On the fundamental side, a recovery in injectables demand across key markets lifted the stock. That mix of performance and visibility is exactly why the stock features among the top performing Nifty Pharma stocks of 2026.
3. Laurus Labs: Completing the List of Top performing Nifty Pharma stocks
Laurus Labs has gained 41.2 percent in 2026 so far, rising from a closing price of Rs 1,108.00 at the end of December 2025 to Rs 1,564.90 as of 20 July 2026. The stock has a 52 week range of Rs 810.05 to Rs 1,579.10, which means it trades about 93 percent above its 52 week low and roughly 1 percent below its 52 week high.
On the fundamental side, a strong recovery in its CDMO business and new contract wins re rated the stock. Investors tracking this name should follow quarterly results closely to judge whether the momentum can sustain.
Talk to a SEBI-Registered Investment Advisor at Univest
Why These Top performing Nifty Pharma stocks Rallied in 2026
Two common threads run through these top performing Nifty Pharma stocks. First, each name delivered earnings or order book growth that stood out within the index, giving investors visibility in an otherwise choppy market. Second, each rode a structural theme with a long runway rather than a one off news spike.
Policy support amplified the moves. Government spending on infrastructure, defence indigenisation, Make in India manufacturing and the energy transition created multi year demand for the businesses behind the top performing Nifty Pharma stocks of this year.
Risks of Chasing Top performing Nifty Pharma stocks Now
Valuation is the biggest risk in top performing Nifty Pharma stocks after a strong run. Winners attract momentum money, and any earnings miss or slowdown in order inflows can trigger sharp corrections from elevated levels.
Concentration is the second risk. Buying only recent winners leaves a portfolio exposed to a single theme reversing. Stagger entries, size positions sensibly and avoid assuming that past returns will repeat.
Liquidity and volatility also matter. Stocks that rise fast can fall just as fast when sentiment turns, and exit doors narrow quickly in weaker names. Keeping a stop loss discipline and reviewing the thesis every quarter protects capital far better than hope.
How to Spot the Next Top performing Nifty Pharma stocks
Screening for the next set of top performing Nifty Pharma stocks starts with earnings growth. Look for companies where profits are compounding faster than the sector, order books are expanding and return ratios are improving year after year.
Next, respect valuations and balance sheets. Reasonable debt, honest management and a price that has not already discounted a decade of growth give future top performing Nifty Pharma stocks room to run. A disciplined checklist beats chasing price charts.
Download the Univest iOS App or Univest Android App to track Granules India, Gland Pharma and Laurus Labs live and get research backed stock ideas.
Conclusion
Granules India, Gland Pharma and Laurus Labs stand out among the top performing Nifty Pharma stocks of 2026, with gains of up to 47.7 percent at a time when the benchmark delivered far more modest returns. Their moves were built on earnings delivery and durable themes rather than pure speculation.
Investors hunting for the best stocks to buy from this list should study fundamentals, diversify across themes and consult a SEBI registered investment advisor before taking fresh positions in these top performing Nifty Pharma stocks.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
FAQs on Top performing Nifty Pharma stocks of 2026
Which are the top performing Nifty Pharma stocks of 2026?
Ans. The top performing Nifty Pharma stocks of 2026 covered in this article are Granules India, Gland Pharma and Laurus Labs, with year to date gains of 47.7 percent, 43.0 percent and 41.2 percent respectively as of 20 July 2026. All returns are calculated from the closing prices of 31 December 2025.
How much has Granules India share price gained in 2026?
Ans. Granules India share price has gained 47.7 percent in 2026 so far, rising from Rs 598.50 at the end of December 2025 to Rs 883.90 as of 20 July 2026. The stock has a 52 week high of Rs 910.00 and a 52 week low of Rs 432.60.
What is the Nifty Pharma index?
Ans. The Nifty Pharma index is an NSE index that tracks a defined basket of listed companies and is widely used to benchmark that segment of the Indian stock market. Investors follow the index and its top constituents to understand where wealth is being created within the segment.
Is it safe to buy top performing Nifty Pharma stocks after a big rally?
Ans. Buying top performing Nifty Pharma stocks after a steep rally carries valuation risk, as winners often trade at a premium to their history and peers. Investors should evaluate earnings growth, order books and valuations carefully, stagger their entries and consult a SEBI registered investment advisor before investing.
What is the 52 week high and low of Gland Pharma?
Ans. Gland Pharma has a 52 week high of Rs 2,573.50 and a 52 week low of Rs 1,573.60. The stock trades at Rs 2,462.00 as of 20 July 2026 after gaining 43.0 percent so far in 2026.
Why did Laurus Labs rally in 2026?
Ans. Laurus Labs gained 41.2 percent in 2026 as a strong recovery in its CDMO business and new contract wins re rated the stock. The stock trades at Rs 1,564.90 as of 20 July 2026 within a 52 week range of Rs 810.05 to Rs 1,579.10.
Where can I track top performing Nifty Pharma stocks live?
Ans. You can track top performing Nifty Pharma stocks live on the Univest app and website, which provide real time prices, charts, fundamentals and research backed trade ideas from SEBI registered research analysts. The NSE and BSE websites also publish official price data for all listed stocks.
